1. Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study.
  2. Singh DK, Srivastava B, Sahu A. Spectrophotometric determination of Rauwolfia alkaloids: estimation of reserpine in pharmaceuticalsAnal Sci. (2004)
  3. Cimolai N, Cimolai T. Yohimbine use for physical enhancement and its potential toxicityJ Diet Suppl. (2011)
  4. Rockhold RW, Gross F. Yohimbine diastereoisomers: cardiovascular effects after central and peripheral application in the ratNaunyn Schmiedebergs Arch Pharmacol. (1981)
  5. Weitzell R, Tanaka T, Starke K. Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbitNaunyn Schmiedebergs Arch Pharmacol. (1979)
  6. Material Safety Data Sheet for Yohimbine hydrochloride.
  7. Asker AF, Helal MA, Motawi MM. Light stability of some parenteral solutions of reserpinePharmazie. (1971)
  8. Jamil N, et al. Studies on the photostability of reserpine in parenteral solutionsPharmazie. (1983)
  9. Strobl GR, et al. Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studiesJ Med Chem. (1993)
  10. Le Corre P, et al. Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolismClin Pharmacol Ther. (2004)
  11. Bharucha AE, et al. Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjectsNeurogastroenterol Motil. (2008)
  12. Ozawa S, et al. Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1Drug Metab Pharmacokinet. (2004)
  13. Taouis M, et al. Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dogJ Pharmacol Exp Ther. (1988)
  14. Szemeredi K, et al. Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in ratsBrain Res. (1991)
  15. Ehlert U, et al. Salivary alpha-amylase levels after yohimbine challenge in healthy menJ Clin Endocrinol Metab. (2006)
  16. Meyerbroeker K, et al. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trialPsychother Psychosom. (2012)
  17. Hedner T, et al. Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteersEur J Clin Pharmacol. (1992)
  18. Grossman E, et al. Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patientsJ Cardiovasc Pharmacol. (1993)
  19. Galitzky J, et al. Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteersEur J Clin Pharmacol. (1990)
  20. Berlan M, et al. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese womenInt J Obes. (1991)
  21. Sturgill MG, et al. Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behaviorJ Cardiovasc Pharmacol. (1997)
  22. Mizuki Y, et al. Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxietyProg Neuropsychopharmacol Biol Psychiatry. (1996)
  23. Kennedy SH, et al. Melatonin responses to clonidine and yohimbine challengesJ Psychiatry Neurosci. (1995)
  24. Arnsten AF. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunctionCNS Drugs. (2009)
  25. Swanson CJ, et al. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the ratNeuropharmacology. (2006)
  26. Gronier B. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptorsEur Neuropsychopharmacol. (2011)
  27. Roychowdhury S, et al. α₂- and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivityPsychopharmacology (Berl). (2012)
  28. Callahan MF, Beales M, Oltmans GA. Yohimbine and rauwolscine reduce food intake of genetically obese (obob) and lean micePharmacol Biochem Behav. (1984)
  29. Jonderko K, Kucio C. Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patientsAliment Pharmacol Ther. (1991)
  30. Clark JT, Smith ER, Davidson JM. Evidence for the modulation of sexual behavior by alpha-adrenoceptors in male ratsNeuroendocrinology. (1985)
  31. Koskinen I, et al. Yohimbine and naloxone: effects on male rat sexual behaviorPhysiol Behav. (1991)
  32. Clark JT, Smith ER, Davidson JM. Enhancement of sexual motivation in male rats by yohimbineScience. (1984)
  33. Rodríguez-Manzo G, Fernández-Guasti A. Reversal of sexual exhaustion by serotonergic and noradrenergic agentsBehav Brain Res. (1994)
  34. Clark JT, Smith ER, Davidson JM. Testosterone is not required for the enhancement of sexual motivation by yohimbinePhysiol Behav. (1985)
  35. Travison TG, et al. The relationship between libido and testosterone levels in aging menJ Clin Endocrinol Metab. (2006)
  36. Guay AT, Jacobson J. Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libidoJ Sex Marital Ther. (2002)
  37. Crespi F. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxietyJ Neurosci Methods. (2009)
  38. Charney DS, Heninger GR, Redmond DE Jr. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidineLife Sci. (1983)
  39. Stine SM, et al. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patientsBiol Psychiatry. (2002)
  40. Gurguis GN, Vitton BJ, Uhde TW. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controlsPsychiatry Res. (1997)
  41. Sommer M, et al. Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controlsPharmacopsychiatry. (2011)
  42. Rimmele U, et al. Trained men show lower cortisol, heart rate and psychological responses to psychosocial stress compared with untrained menPsychoneuroendocrinology. (2007)
  43. Cameron OG, et al. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humansPsychosom Med. (2000)
  44. Powers MB, et al. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentationJ Anxiety Disord. (2009)
  45. Gentili A, et al. Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trialEur J Clin Pharmacol. (1996)
  46. Anderson KJ, Revelle W. Impulsivity and time of day: is rate of change in arousal a function of impulsivityJ Pers Soc Psychol. (1994)
  47. Winstanley CA, Eagle DM, Robbins TW. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studiesClin Psychol Rev. (2006)
  48. Brennan AR, Arnsten AF. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical functionAnn N Y Acad Sci. (2008)
  49. Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorderDepress Anxiety. (2008)
  50. Casada JH, Roache JD. Behavioral inhibition and activation in posttraumatic stress disorderJ Nerv Ment Dis. (2005)
  51. Swann AC, et al. Acute yohimbine increases laboratory-measured impulsivity in normal subjectsBiol Psychiatry. (2005)
  52. Sun H, et al. Yohimbine increases impulsivity through activation of cAMP response element binding in the orbitofrontal cortexBiol Psychiatry. (2010)
  53. Shamloul R. Natural aphrodisiacsJ Sex Med. (2010)
  54. Double Blind Trial of Yohimbine Hydrochloride in the Treatment of Erection Inadequacy.
  55. Morales A, et al. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trialJ Urol. (1987)
  56. Mann K, et al. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunctionArch Sex Behav. (1996)
  57. Reid K, et al. Double-blind trial of yohimbine in treatment of psychogenic impotenceLancet. (1987)
  58. Vogt HJ, et al. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunctionInt J Impot Res. (1997)
  59. Susset JG, et al. Effect of yohimbine hydrochloride on erectile impotence: a double-blind studyJ Urol. (1989)
  60. Rowland DL, Kallan K, Slob AK. Yohimbine, erectile capacity, and sexual response in menArch Sex Behav. (1997)
  61. Kernohan AF, et al. An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjectsBr J Clin Pharmacol. (2005)
  62. Lebret T, et al. Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunctionEur Urol. (2002)
  63. Carmen GY, Víctor SM. Signalling mechanisms regulating lipolysisCell Signal. (2006)
  64. Liu CY, Boyer JL, Mills SE. Acute effects of beta-adrenergic agonists on porcine adipocyte metabolism in vitroJ Anim Sci. (1989)
  65. Lafontan M, et al. Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategiesAm J Clin Nutr. (1992)
  66. Doxey JC, et al. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthineNaunyn Schmiedebergs Arch Pharmacol. (1984)
  67. Lalchandani SG, et al. Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtypeJ Pharmacol Exp Ther. (2002)
  68. MacDonald E, Kobilka BK, Scheinin M. Gene targeting–homing in on alpha 2-adrenoceptor-subtype functionTrends Pharmacol Sci. (1997)
  69. Tan S, Curtis-Prior PB. Comparative effects of RX 781094, mianserin, yohimbine, rauwolscine and prazosin in reversing clonidine inhibition of MIX-stimulated lipolysis in hamster isolated white fat cellsPharmacol Res Commun. (1984)
  70. Reiner S, et al. Differential signaling of the endogenous agonists at the beta2-adrenergic receptorJ Biol Chem. (2010)
  71. Greenway FL, Bray GA, Heber D. Topical fat reductionObes Res. (1995)
  72. Greenway FL, Bray GA. Regional fat loss from the thigh in obese women after adrenergic modulationClin Ther. (1987)
  73. Pedersen SB, et al. Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distributionJ Clin Endocrinol Metab. (2004)
  74. Keller U, Weiss M, Stauffacher W. Contribution of alpha- and beta-receptors to ketogenic and lipolytic effects of norepinephrine in humansDiabetes. (1989)
  75. Galitzky J, et al. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteersEur J Clin Invest. (1988)
  76. McCarty MF. Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysisMed Hypotheses. (2002)
  77. Ito K, et al. Adrenoceptor antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion from perfused rat pancreasDiabetes Res Clin Pract. (1995)
  78. Ribes G, et al. Involvement of a central nervous pathway in yohimbine-induced insulin secretionEur J Pharmacol. (1989)
  79. Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer playersRes Sports Med. (2006)
  80. Sax L. Yohimbine does not affect fat distribution in menInt J Obes. (1991)
  81. Biaggioni I, Robertson RM, Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failureJ Clin Pharmacol. (1994)
  82. Shibao C, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failureHypertension. (2010)
  83. Sandberg M, et al. The α2-Adrenoceptor Antagonist Yohimbine Normalizes Increased Islet Blood Flow in GK Rats: A Model of Type 2 DiabetesHorm Metab Res. (2012)
  84. Adeghate E, Ponery AS, Wahab A. Effect of electrical field stimulation on insulin and glucagon secretion from the pancreas of normal and diabetic ratsHorm Metab Res. (2001)
  85. Guay AT, et al. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trialInt J Impot Res. (2002)
  86. Cuneo RC, et al. Effects of alpha-2 adrenoreceptor blockade by yohimbine on the hormonal response to hypoglycaemic stress in normal manHorm Metab Res. (1989)
  87. Krystal JH, et al. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjectsAm J Psychiatry. (1996)
  88. McDougle CJ, et al. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbinePsychopharmacology (Berl). (1995)
  89. Mattila M, Seppala T, Mattila MJ. Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepamInt Clin Psychopharmacol. (1988)
  90. Senbel AM, Mostafa T. Yohimbine enhances the effect of sildenafil on erectile process in ratsInt J Impot Res. (2008)
  91. Jordan J, Sharma AM. Potential for sibutramine-yohimbine interactionLancet. (2003)
  92. Waluga M, et al. Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese womenClin Physiol. (1998)
  93. Schuckit MA. Subjective responses to alcohol in sons of alcoholics and control subjectsArch Gen Psychiatry. (1984)
  94. Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported casesAnn Pharmacother. (2010)
  95. Linden CH, Vellman WP, Rumack B. Yohimbine: a new street drugAnn Emerg Med. (1985)
  96. HOLMBERG G, GERSHON S. Autonomic and psychic effects of yohimbine hydrochloridePsychopharmacologia. (1961)
  97. Cohen PA, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USADrug Test Anal. (2015)
  98. Giampreti A, et al. Acute neurotoxicity after yohimbine ingestion by a body builderClin Toxicol (Phila). (2009)
  99. Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trialsJ Urol. (1998)
  100. Umhau JC, et al. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosateNeuropsychopharmacology. (2011)